Covista Inc. vs Stride, Inc., two Education stocks. A side-by-side on valuation, growth, margins, returns, and what each price is betting.
Where CVSA and LRN diverge most: on current ratio, CVSA reads 0.70 and LRN reads 6.21; on debt / equity, CVSA reads 0.37 and LRN reads 0.25. The rest of the comparable metrics sit closer together. What CVSA's price implies is a bet that sits within the historical range (whole-company basis). What LRN's price implies is a bet that sits within the historical range (whole-company basis). The bull and bear cases for each are in their full reports below.
| Metric | CVSA | LRN |
|---|---|---|
| Price | $115.67 | $86.73 |
| Market cap | $4.0B | $4.0B |
| Sector | Education | Education |
| Stage | Mature | Mature |
| Implied growth (priced in) | +0.3% | — |
| P/E | 18.1 | 13.5 |
| P/B | 2.95 | 2.42 |
| P/S | 2.11 | 1.57 |
| EV/EBITDA | 10.7 | 8.8 |
| Revenue growth | +9.8% | +11.3% |
| Gross margin | — | 36.8% |
| Operating margin | 18.8% | 20.5% |
| Net margin | 12.3% | 12.2% |
| Return on equity | 17.2% | 18.8% |
| Return on assets | 8.6% | 12.6% |
| Return on invested capital | 14.5% | 15.4% |
| FCF yield | 8.4% | 10.4% |
| Debt / equity | 0.37 | 0.25 |
| Current ratio | 0.70 | 6.21 |
| Altman Z (solvency) | 4.00 | 5.53 |
| Piotroski F (quality) | 6 / 9 | 6 / 9 |
Each week boothcheck ranks the stocks whose prices are betting on the most. Read the most stretched bets archive →
boothcheck is also on Android. Get the app on Google Play →
The stronger value is highlighted per metric where one is strictly better on that single number; it is not an overall verdict on either company. For informational and research purposes only. Not investment advice. Not a recommendation to buy, sell, or hold any security. boothcheck is not a registered investment adviser. Past performance does not guarantee future results.